Advanced Enzytech Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-07-2024
- Paid Up Capital ₹ 0.70 M
as on 15-07-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 25.55%
(FY 2022)
- Profit 14.76%
(FY 2022)
- Ebitda 28.28%
(FY 2022)
- Net Worth 20.30%
(FY 2022)
- Total Assets 10.02%
(FY 2022)
About Advanced Enzytech Solutions
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M, as per Ministry of Corporate Affairs (MCA) records.
Mukund Kabra, Beni Rauka, and Dipak Roda serve as directors at the Company.
- CIN/LLPIN
U24200MH2008PLC186383
- Company No.
186383
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2008
- Date of AGM
20 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Advanced Enzytech Solutions?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukund Kabra  | Director | 13-Jun-2019 | Current |
| Beni Rauka | Director | 01-Sep-2008 | Current |
| Dipak Roda | Director | 23-Jun-2009 | Current |
Financial Performance and Corporate Structure Insights of Advanced Enzytech Solutions.
Advanced Enzytech Solutions Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.55% increase. The company also saw a substantial improvement in profitability, with a 14.76% increase in profit. The company's net worth Soared by an impressive increase of 20.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Enzytech Solutions?
In 2021, Advanced Enzytech Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Scitech Specialities Private LimitedActive 17 years 1 monthMukund Kabra and Beni Rauka are mutual person
Saiganesh Enzytech Solutions Private LimitedActive 2 years 1 monthMukund Kabra and Beni Rauka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanced Enzytech Solutions?
Unlock and access historical data on people associated with Advanced Enzytech Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Enzytech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Enzytech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
